Magnetotherapy in Rheumatoid Arthritis Treatment
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Hand Rheumatism
- Rheumatoid Arthritis
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 35 years and 80 years
- Gender
- Both males and females
Description
Participants with rheumatoid arthritis with recommendation to physiotherapy. All participants have dysfunction and pain of hand. Inclusion criteria: II ° and III ° of advancement of radiological changes II ° and III ° of advancement of functional changes Remission, low or moderate RA activity: DAS28...
Participants with rheumatoid arthritis with recommendation to physiotherapy. All participants have dysfunction and pain of hand. Inclusion criteria: II ° and III ° of advancement of radiological changes II ° and III ° of advancement of functional changes Remission, low or moderate RA activity: DAS28 Medical order Magnetotherapy and kinesiotherapy Kinesiotherapy Consent to participate in the study Completion of the research program Exclusion criteria: Additional physiotherapy treatments for the hands Change in type or dose of pharmacotherapy used Taking steroid anti-inflammatory drugs Malaise and side effects in the subject Outcome Measures: Duration of morning stiffness The degree of severity of morning stiffness Pain intensity assessment (VAS) Test Box & Blocks Measurement of the palmar surface of the hand Measuring the range of motion in the joints of the hand Measurement of compression force in a cylindrical grip Time to maintain maximum pressure during cylindrical grip Hand volume measurement HAQ-20 test Intervention: Group 1: Only kinesiotherapy Group 2: Kinesiotherapy with bipolar magnetic field Group 3: Kinesiotherapy with unipolar magnetic field Assessment: Immediately before start therapy Immediately after therapy (10 treatments in 2 weeks)
Tracking Information
- NCT #
- NCT04426513
- Collaborators
- Not Provided
- Investigators
- Not Provided